Fibromyalgia: Helping Your Patient While Maintaining Your Sanity

Motley, Carol P.; Maxwell, Meredith L.

doi:10.1016/j.pop.2010.07.007

Cited by 2 publications

(4 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, an appropriate explanation that fibromyalgia is a non-destructive disorder should improve understanding and acceptance that there is no 'instant cure' for the illness, and encouragement should be given towards self-management methods, altering the patient’s perception of the illness from one of incapability to an optimistic sense of self-efficacy. 33 , 34 The literature demonstrated ways in which an explanation of the diagnosis should be expressed to patients, including advising them that the way in which their central nervous system processes pain is altered, processing pain signals atypically, resulting in increased pain sensation. Terms such as an ‘abnormal volume control setting’ and ‘oversensitive car alarm’ were frequently used.…”

Section: Resultsmentioning

confidence: 99%

“…Upon diagnosis, an appropriate explanation of the pathophysiology, symptoms, management and prognosis should be provided to validate the patient's symptoms and improve understanding and acceptance, and has been acknowledged as a critical element in fibromyalgia management (5,21,22). Furthermore, an appropriate explanation that fibromyalgia is a non-destructive disorder, should improve understanding and acceptance that there is no "instant cure" for the illness, and encouragement should be given towards self-management methods, altering the patient's perception of the illness from one of incapability to an optimistic sense of selfefficacy (22,23). The literature demonstrated ways in which an explanation of the diagnosis should be expressed to patients, including advising patients that the way in which their central nervous system processes pain is altered, processing pain signals atypically, resulting in increased pain sensation.…”

Section: Patient Educationmentioning

confidence: 99%

See 1 more Smart Citation

Explaining a diagnosis of fibromyalgia in primary care: a scoping review

2023

View full text Add to dashboard Cite

BackgroundFibromyalgia is a common cause of chronic pain in the UK, with a huge individual and societal impact. Despite this, it remains difficult to diagnose and treat. The explanation of a fibromyalgia diagnosis can lead to difficult therapeutic relationships, with attitudinal issues and negative profiling of patients. This can lead to frustration, and have a harmful impact on health outcomes.AimTo review how an explanation of a fibromyalgia diagnosis is provided in primary care in order to establish a model of best practice when educating patients on their diagnosis.Design & SettingScoping ReviewMethodMEDLINE, EMBASE, Web of Science, and grey literature were searched. Articles were extracted, reviewed and analysed according to the inclusion criteria.ResultsTwenty-nine records met the inclusion criteria. Six overarching themes were identified: Patient Education, Physician Education, Importance of the Multidisciplinary Team, Importance of Patient Centred Care, The Value of Primary Care and Useful Resources. The literature illustrates that describing fibromyalgia using analogies to illustrate the pain sensitisation process, can help patients understand their diagnosis better. This improves their willingness to accept management plans, particularly engagement with non-pharmacological therapies, which the literature suggests are best delivered within a multi-disciplinary team.ConclusionKey aspects of fibromyalgia should be explained to patients in order for them to gain a better understanding of their diagnosis. A 'one size fits all' model for explaining the fibromyalgia diagnosis to patients is inappropriate because patients' experiences are so individualised. Further research is required on whether different explanations impact patient outcomes.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Patient Educationmentioning

confidence: 99%

Explaining a diagnosis of fibromyalgia in primary care: a scoping review

2023

View full text Add to dashboard Cite

show abstract

“…Eligible studies had to meet the following criteria: (a) randomized controlled trials or prospective cohort studies; (b) enrollment of fibromyalgia patients who received vitamin D supplementation; (c) reporting of psychological outcomes and quality of life, measured by the 36-item Short Form Health Survey (SF-36), FIQ, Beck Depression Inventory (BDI), VAS, Widespread pain index (WPI), or Pittsburgh Sleep Quality Index (PSQI); and (d) published in English or Chinese. Articles reporting a case or series of cases, review articles, animal studies, conference abstracts, editorials, and letters were excluded ( Supplementary Table S2 , [ 4 , 5 , 7 , 10 , 14 , 18 , 25 , 29 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 ,…”

Section: Methodsmentioning

confidence: 99%

“…Table S2: Reasons for exclusion of the articles. References [ 4 , 5 , 7 , 10 , 14 , 18 , 25 , 29 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 ,…”

unclassified

Psychological Outcomes and Quality of Life of Fibromyalgia Patients with Vitamin D Supplementation—A Meta-Analysis

Yang

Tsai

Ting

et al. 2023

JCM

View full text Add to dashboard Cite

The efficacy of current pharmaceutical treatments for fibromyalgia are limited. Vitamin D has shown promise in relieving pain. However, there is a lack of comprehensive analysis of psychological outcomes with vitamin D supplementation in fibromyalgia. This study aimed to investigate the impact of vitamin D supplementation on psychological outcomes and quality of life in fibromyalgia patients, given the unmet clinical need for effective treatment options. A meta-analysis of randomized controlled trials comparing vitamin D to placebo and prospective studies examining changes before and after vitamin D supplementation for patients with fibromyalgia was conducted to evaluate the effects of vitamin D on psychological outcomes, quality of life, and pain scores in patients with fibromyalgia. Databases were searched for relevant articles published from earliest available date to October 31, 2022. (PROSPERO number, CRD42022369889). We included 8 trials with a total of 694 participants and found that vitamin D supplementation had significant positive effects on physical function (standard mean differences (SMD) = 0.44, 95% CI = [0.10, 0.77 ]), role limitations due to emotional health (SMD = 0.57, 95% CI = [0.32, 0.82]), social function (SMD = 0.50, 95% CI = [0.08, 0.93]), and general health (SMD = 0.36, 95% CI = [0.11, 0.61]). Improvement of the Fibromyalgia Impact Questionnaire (FIQ) scores was noted (SMD = −0.414, 95% CI = [−0.808, −0.021]), but not on the Visual Analog Scale (VAS) (SMD = −0.15, 95% CI = [−0.771, 0.471]) and the Beck’s Depression Inventory (BDI) scores (SMD = −0.456, 95% CI = [−1.27, 0.30]). In conclusion, vitamin D supplementation might be an alternative option for improvement of psychological outcomes and quality of life in patients with fibromyalgia.

show abstract

Fibromyalgia: Helping Your Patient While Maintaining Your Sanity

Cited by 2 publications

References 25 publications

Explaining a diagnosis of fibromyalgia in primary care: a scoping review

Explaining a diagnosis of fibromyalgia in primary care: a scoping review

Psychological Outcomes and Quality of Life of Fibromyalgia Patients with Vitamin D Supplementation—A Meta-Analysis

Contact Info

Product

Resources

About